JAVYGTOR
Generic: SAPROPTERIN DIHYDROCHLORIDE
Dr. Reddys Laboratories IncManufacturer
ORALRoute
SAPROPTERIN DIHYDROCHLORIDEActive Substance
2021-03-30Original Approval
JAVYGTOR is FDA application ANDA209452, sponsored by DR REDDYS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class I2024-04-08
Javygtor (sapropterin dihydrochloride) Powder for Oral Solution 100mg, 30 individual packets per carton, Rx Only, DistriSub-potent Drug; powder discoloration associated with decreased potency
Class III2024-11-22
Javygtor (sapropterin dihydrochloride) Tablets 100mg, 120-count bottle, Rx Only, Distributor: Dr. Reddy's Laboratories IFailed Impurities/Degradation Specifications
Top Reported Reactions
1
OVERDOSE
165 reports
2
PRODUCT PRESCRIBING ERROR
159 reports
3
PRODUCT DOSE OMISSION ISSUE
95 reports
4
ILLNESS
48 reports
5
HEADACHE
47 reports
6
VOMITING
42 reports
7
EXPOSURE DURING PREGNANCY
41 reports
8
DIARRHOEA
38 reports
9
NAUSEA
36 reports
10
DRUG INEFFECTIVE
34 reports